Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 153.36 | 98.26 | 56 |
| OPM % | 32.28 | 23.68 | - |
| PBDT | 48.73 | 19.86 | 145 |
| PBT | 40.64 | 15.97 | 154 |
| NP | 32.38 | 12.84 | 152 |